International Journal of Radiation Biology · 1991 · 13 citations · 19 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyPharmacokinetics Of Anticancer AgentsCancer MetabolismMalignant NeoplasmsOncology PharmacologyOxygen Consumption In TumorsOxygen Diffusion In TumorsOxygenationTransport In Tumor TissueTumor Acidity ModulationTumor Oxygenation
Using laser Doppler flowmetry, we investigated the effects of Fluosol-DA 20% on RBC flux in FSaII tumours and on RBC flux in normal skin of C3H mice. The RBC flux in tumours was significantly increased; however, the RBC flux in normal skin fluctuated only slightly after the treatment with Fluosol-DA 20%. Since an increase in RBC flux by Fluosol-DA 20% may facilitate the removal of acidic metabolites from the tumours, the effects of Fluosol-DA 20% on intratumour pH was also measured. We also measured intratumour pO2 after various dosages of Fluosol-DA 20% with carbogen inhalation. We concluded that the administration of Fluosol-DA 20% selectively increased the RBC flux in tumours compared to that in normal skin. Moreover, carbogen inhalation combined with increasing dosages up to 36 ml/kg of Fluosol-DA 20% effectively enhanced tumour oxygenation in FSaII tumours.
19
The American Journal of Physiology
The American Naturalist · 1899 · 5.7K citations
Advances in blood substitute research
Alexander McLeod · FEBS Letters · 1984 · 134 citations
Increase in pO2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen.
Chang W. Song, Intae Lee, Takeo Hasegawa et al. · PubMed · 1987 · 104 citations
Medicine, Oncology, Pharmacology +16